OTCM
NMMCF
Mar 27, Last price
0.00
Name
NMC Health PLC
Chart & performance
P/E
—
P/S
—
EPS
0.12
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
23.62%
Div Yld LY
—
Div Yld TTM
—
Revenues
2.06b
+28.31%
Net income
249m
+33.71%
CFO
388m
+39.75%
Dividend
Jun 13, 20190.181 /sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
NMC Health plc operates as a global healthcare provider, extending its comprehensive medical services across various regions, including the United Arab Emirates, the United Kingdom, and Spain. The enterprise holds ownership and administrative responsibility for a wide array of healthcare facilities, such as hospitals, medical centers, long-term residential care units, outpatient surgical clinics, fertility treatment centers, and providers of in-home health assistance. Its service portfolio encompasses essential medical diagnostics, inpatient treatments, and outpatient consultations. Additionally, NMC Health conducts research and offers specialized medical expertise in the fields of gynecology, obstetrics, and human procreation. Beyond direct patient care, the company also provides management solutions for hospitals and engages in the retail distribution of pharmaceutical goods. Established in 1974, NMC Health plc is headquartered in London, United Kingdom.
Related entities
Subsidiaries (2)
N.M.C HEALTH CARE (L.L.C.)
NMC HEALTH (JERSEY) LIMITED
Key people
Prashanth Shenoy
Chief Financial Officer · since 2017
Hani Buttikhi
Chief Investment Officer, Executive Director · since 2017
Prasanth Manghat
Chief Executive Officer, Executive Director · since 2017
Chandrakumari Bavaguthu Raghuram Shetty
Group Medical Director · since 2013
Simon Watkins
Group Company Secretary
Non-Executive Director · since 2020
Ayesha Abdullah
Non-Executive Independent Director · since 2014
Lord Clanwilliam
Non-Executive Independent Director · since 2012
Headquarters & legal address
LEVEL 1, DEVONSHIRE HOUSE
ONE MAYFAIR PLACE, MAYFAIR
LONDON, LND W1J 8AJ
GB
ONE MAYFAIR PLACE, MAYFAIR
LONDON, LND W1J 8AJ
GB
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY |
|---|---|---|---|
| 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||
Revenues | |||
Cost of revenue | |||
Unusual Expense (Income) | |||
NOPBT | |||
NOPBT Margin | |||
Operating Taxes | |||
Tax Rate | |||
NOPAT | |||
Net income | |||
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | |||
BB yield | |||
| Debt | |||
Debt current | |||
Long-term debt | |||
Deferred revenue | |||
Other long-term liabilities | |||
Net debt | |||
| Cash flow | |||
Cash from operating activities | |||
CAPEX | |||
Cash from investing activities | |||
Cash from financing activities | |||
FCF | |||
| Balance | |||
Cash | |||
Long term investments | |||
Excess cash | |||
Stockholders' equity | |||
Invested Capital | |||
ROIC | |||
ROCE | |||
| EV | |||
Common stock shares outstanding | |||
Price | |||
Market cap | |||
EV | |||
EBITDA | |||
EV/EBITDA | |||
Interest | |||
Interest/NOPBT |